Guoen Shares released its 2026 half-year report, with first-half net profit attributable to the parent of 655 million yuan, up 89.3% year-on-year, and operating revenue of 11.51 billion yuan, up 18.1% year-on-year. Second-quarter net profit attributable to the parent was 398 million yuan, up 69.6% year-on-year. The company's business changes were mainly concentrated in chemical new materials and the biomedical and health industries. In chemical new materials, it has formed a complete industrial chain based on styrene, and in biomedicine, it has expanded gelatin and collagen applications through its controlling stake in Dongbao Bio.
Qingdao Gon Technology Co Ltd
Baotou Dongbao Bio-Tech Co Ltd